MARKET

DRMA

DRMA

Dermata Therapeutics Inc
NASDAQ
0.2800
-0.0198
-6.60%
After Hours: 0.2851 +0.0051 +1.82% 18:30 02/07 EST
OPEN
0.2938
PREV CLOSE
0.2998
HIGH
0.3100
LOW
0.2800
VOLUME
124.58K
TURNOVER
0
52 WEEK HIGH
1.820
52 WEEK LOW
0.1621
MARKET CAP
3.45M
P/E (TTM)
-0.2016
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 01/17 21:31
Why Geron Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Benzinga · 01/05 13:01
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 01/03 18:39
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 01/03 17:30
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 01/03 13:05
Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket
Benzinga · 01/03 12:55
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 01/02 17:30
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 01/02 13:05
More
About DRMA
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company. The Company is focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its products candidates, DMT310 and DMT410. Its lead product candidate DMT310, is intended to utilize its Spongilla technology for a once weekly treatment of a variety of skin diseases with its initial focus being for the treatment of acne vulgaris. DMT310 is in Phase II clinical trial for the treatment of rosacea. Its second product candidate utilizing its Spongilla technology is its combination treatment, DMT410. DMT410 is intended to consist of one treatment of its sponge powder followed by one topical application of botulinum toxin for delivery into the dermis. DMT410 Phase I POC trial of DMT410 for the treatment of multiple aesthetic skin conditions.

Webull offers kinds of Dermata Therapeutics Inc stock information, including NASDAQ:DRMA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DRMA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DRMA stock methods without spending real money on the virtual paper trading platform.